Continued outperformance in Prestige & Above (P&A) in Q4FY23 driven by portfolio reshape initiatives through innovations and renovations is pleasing. Further, balanced volume (~10% YoY) and price / mix growth (~12% YoY) in Q4FY23 vs largely mix driven growth in previous few quarters is also good though it had benefits of BIO normalisation.